Month: April 2015

WHAT IS THE IMPACT OF ADDING EXTRA HEALTH DIMENSIONS TO THE EQ-5D?

Oxford, UK  –  Generic preference-based measures of health are commonly used to evaluate the impact of diseases and their treatments on overall health related quality of life by weighting their dimensions using people’s value judgements. However, these measures, including the

Posted in Preference-Based Assessments, Value in Health Tagged with: , , , , , ,

HEALTH CARE DECISION MAKERS OPEN FOR PUBLIC AND PATIENT INVOLVEMENT IN COVERAGE DECISIONS

Brussels, Belgium – In a democratic system, politicians are elected to make decisions regarding health care priorities. In deliberation-driven systems, such as in Belgium, coverage decisions are based on the outcomes of a deliberation amongst stakeholders (including public authorities, providers,

Posted in Health Policy Analyses, Value in Health Tagged with: , , ,

IDENTIFYING THE FACTORS THAT ENHANCE POSITIVE DRUG REIMBURSEMENT RECOMMENDATION IN SCOTLAND

Rotterdam, The Netherlands – Given limited health care resources and rising expenditures on pharmaceuticals, policy makers are increasingly confronted with the challenging task to improve patient outcomes and reimburse new pharmaceutical interventions. Arguably, Scotland is often one of the first

Posted in Announcements, Health Policy Analyses, Value in Health Tagged with: , , , , , ,